Biogen Inc (BIIB)
146.47
-0.92
(-0.62%)
USD |
NASDAQ |
Dec 20, 16:00
147.55
+1.08
(+0.74%)
After-Hours: 20:00
Biogen Total Liabilities (Quarterly): 11.95B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Pfizer Inc | 126.92B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Sage Therapeutics Inc | 70.60M |
| Moderna Inc | 3.876B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.31B |
| Shareholders Equity (Quarterly) | 16.36B |
| Debt to Equity Ratio | 0.3847 |
| Current Ratio | 1.259 |
| Net Debt Paydown Yield | -0.01% |